Financial News
Articles published by Longboard Pharmaceuticals, Inc.
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
August 02, 2024
Via Business Wire
Tickers
LBPH
Via Business Wire
Tickers
LBPH
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
April 02, 2024
Via Business Wire
Tickers
LBPH
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
March 01, 2024
Via Business Wire
Tickers
LBPH
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
February 02, 2024
Via Business Wire
Tickers
LBPH
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February
February 01, 2024
Via Business Wire
Tickers
LBPH
Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
January 03, 2024
Via Business Wire
Tickers
LBPH
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock
January 02, 2024
Via Business Wire
Tickers
LBPH
Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 03, 2023
Via Business Wire
Tickers
LBPH
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 02, 2023
Via Business Wire
Tickers
LBPH
Longboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in November
November 01, 2023
Via Business Wire
Tickers
LBPH
Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on October 11, 2023
September 19, 2023
Via Business Wire
Tickers
LBPH
Via Business Wire
Tickers
LBPH
Via Business Wire
Tickers
LBPH
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.